D
Xeris Biopharma Holdings, Inc. XERS
$5.01 -$0.15-2.91% NASDAQ
Recommendation
Prev Close
$5.16
Volume
2,547,953
Avg Vol (90D)
2,632,173
Market Cap
$806.94M
Dividend & Yield
--
52-Week Range
$1.72 - $6.07
P/E (TTM)
--
EPS (TTM)
-$0.3761
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
XERS: Oppenheimer Raises Price Target for Xeris Biopharma Holdings XERS Stock News
5/9/2025 - GuruFocus
Xeris Biopharma Holdings (XERS, $5.16) price moved above its 50-day Moving Average on May 08, 2025
5/9/2025 - Tickeron - Stocks
Xeris Biopharma Holdings (XERS, $5.16) price may drop as it broke higher Bollinger Band on May 08, 2025
5/9/2025 - Tickeron - Stocks
Tudor Investment Corp ET AL Reduces Stock Holdings in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)
5/9/2025 - MarketBeat
Xeris Biopharma Holdings Inc (XERS) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ...
5/9/2025 - GuruFocus
Q1 2025 Xeris Biopharma Holdings Inc Earnings Call Transcript
5/9/2025 - GuruFocus
Xeris Biopharma Holdings, Inc. (XERS) Q1 2025 Earnings Call Transcript
5/8/2025 - SeekingAlpha
Xeris Biopharma Holdings, Inc. (XERS) Q1 2025 Earnings Call Transcript
5/8/2025 - Seeking Alpha: Transcripts
Xeris Biopharma (XERS) Reports Q1 Loss, Tops Revenue Estimates
5/8/2025 - Zacks Investment Research
Xeris Biopharma Holdings Inc (XERS) Q1 2025 Earnings: Revenue Surpasses Estimates at $60. ...
5/8/2025 - GuruFocus
Xeris Biopharma Reports Record First Quarter 2025 Financial Results
5/8/2025 - Business Wire
Xeris Biopharma Holdings: Looking For More Growth In Q1 Earnings
5/7/2025 - SeekingAlpha
Earnings Outlook For Xeris Biopharma Holdings
5/7/2025 - Benzinga
Xeris Biopharma Holdings (XERS, $4.3) Stochastic Oscillator left the overbought zone on May 06, 2025
5/7/2025 - Tickeron - Stocks
Corcept Therapeutics (CORT) Meets Q1 Earnings Estimates
5/5/2025 - Zacks Investment Research
Xeris Biopharma Holdings (XERS, $4.71) price may drop as it broke higher Bollinger Band on May 02, 2025
5/3/2025 - Tickeron - Stocks
Xeris Biopharma Holdings (XERS, $4.71) price moved above its 50-day Moving Average on May 02, 2025
5/3/2025 - Tickeron - Stocks
Xeris Biopharma (XERS) Projected to Post Earnings on Thursday
5/3/2025 - MarketBeat
Xeris Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025
5/1/2025 - Business Wire
Xeris Biopharma Holdings (XERS, $4.57) price moved above its 50-day Moving Average on April 30, 2025
5/1/2025 - Tickeron - Technical Analysis
Xeris Biopharma Holdings (XERS, $4.57) price may drop as it broke higher Bollinger Band on Apr 30, 2025
5/1/2025 - Tickeron - Technical Analysis
Xeris Biopharma (NASDAQ:XERS) Sees Large Volume Increase - Time to Buy?
4/30/2025 - MarketBeat
Xeris Biopharma Holdings (XERS, $4.41) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 29, 2025
4/30/2025 - Tickeron - Stocks
Analysts Expect Breakeven For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Before Long
4/29/2025 - Simply Wall St
Xeris Biopharma Holdings (XERS, $4.31) Stochastic Oscillator left the overbought zone on April 25, 2025
4/26/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$203.07M
EBITDA (TTM)
-$15.48M
EBIT (TTM)
-$27.55M
Net Income (TTM)
-$54.84M
Balance Sheet
Total Assets (Q)
$323.06M
Total Debt (Q)
$271.45M
Total Liabilities (Q)
$352.68M
Book Value Per Share (Q)
-$0.1982
Cash Flow
Cash from Operations (TTM)
-$36.98M
Cash from Investing (TTM)
$4.88M
Cash from Financing (TTM)
$36.17M
Net Change in Cash (TTM)
$4.07M
Filings
Filing Date
Thursday, March 6, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
1.49
7-Day Total Return
9.63%
30-Day Total Return
-11.01%
60-Day Total Return
39.94%
90-Day Total Return
46.06%
Year to Date Total Return
44.80%
1-Year Total Return
166.49%
2-Year Total Return
83.52%
3-Year Total Return
172.28%
5-Year Total Return
--
52-week Low
May 09, 2024 - $1.72
52-week High
Mar 26, 2025 - $6.07
Valuation
Market Cap
$806.94M - Small Cap
Enterprise Value
$1.02B
Price/Sales (TTM)
3.79
Price/Book (Q)
-26.03
Dividends and Shares
Shares Outstanding
149.09M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.xerispharma.com
Phone Number
844 445 5704
Address
1375 West Fulton Street
Chicago, IL 60607
Country
United States
Year Founded
2005
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The... more
NASDAQ 05/09/2025 4:00PM Eastern Quotes delayed